Bright Minds Biosciences Inc. (TSE:DRUG) has released an update.
Bright Minds Biosciences Inc. has reported a decrease in total assets from CAD 6.88 million to CAD 6.53 million in the six-month period ending March 31, 2024, alongside an increase in total liabilities from CAD 280,856 to CAD 845,787. The company’s shareholders’ equity saw a reduction from CAD 6.6 million to CAD 5.69 million, with a net comprehensive loss widening to CAD 2.26 million for the quarter.
For further insights into TSE:DRUG stock, check out TipRanks’ Stock Analysis page.
